about
Hard surface biocontrol in hospitals using microbial-based cleaning productsImpact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome RemodulationChronic sleep deprivation markedly reduces coagulation factor VII expressionActivation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant.Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations.Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency.Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity.Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study.Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation.An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes.Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis/activity.The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X.Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B.Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAsCoagulation factor VII variants resistant to inhibitory antibodiesThe chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutationAkt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growthTailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contextsTranslational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variantsAn Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia AFunctional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentratesA recoded view on the F9 p.Cys178Ter pathogenic mechanismMolecular Mechanisms and Determinants of Innovative Correction Approaches in Coagulation Factor DeficienciesMissense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal conditionThe carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies
P50
Q28543303-1FE541C7-FABC-48F3-8C92-89D97F92B9A2Q28550229-788B1C7D-15E3-4F84-9985-A9D968663560Q34032289-532D790C-8616-435B-B9DC-F6E1BF40BDDFQ37209107-23C4BD30-0238-4CDC-A401-FFC70141D5C6Q37457665-D6C6A700-5D05-492A-B33F-DC933E68175BQ38961683-2A9547B1-5536-4BA1-B9F8-EE2A0523FA3EQ39499656-CC1EEF46-767D-4EC5-B05F-FDB2525F77FCQ39901682-F37A05EE-2EBE-4C74-AF5A-E8E6F988376EQ40809666-DCB63EE6-685D-4536-B52F-CA9DAD02DEF6Q40900385-EAC6A2B8-17E8-4727-9E03-8D87DED9DE12Q42541172-D11979DD-624D-48DD-912F-8E360F06DE0BQ45874943-2FF532EF-E803-4ADC-99F1-E2AC476FE28AQ48171352-CEC5AE70-3EA9-4465-89CA-35CB32330780Q49503585-B3EC8AE1-BA9B-4575-935C-07B9F14B8858Q58580788-1B9DC11F-C081-4853-9ED1-3A533048405AQ87524760-14BC8A2A-186F-4384-B4EA-A327B4E13F0CQ89546491-445C8A28-DDCF-4A9A-92E1-975F5CD06A28Q90028792-45C374C1-488F-482B-A117-9EFEDEBECF7AQ90041111-BB1F025E-ED84-491A-A40D-A4D528379F1EQ90713160-BA8871BE-3C9A-44CC-BFC6-35BAC0AE138BQ90931579-66FF2BF8-C783-40AA-9DD0-87D2401FF128Q91766073-6E5240A7-55F1-402A-85D4-2B03661B5B2DQ92919768-F479A5EC-384D-4851-94DE-14A5CFD5EEFFQ92989928-428BF06E-AE49-4BCB-B398-72FB9CBF184FQ93149139-C1F8773D-0A26-4004-9790-3F0CA0AF4D3CQ93213690-C2758CF4-3187-4E9D-AEE2-548507260CD5
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Alessio Branchini
@ast
Alessio Branchini
@en
Alessio Branchini
@es
Alessio Branchini
@nl
type
label
Alessio Branchini
@ast
Alessio Branchini
@en
Alessio Branchini
@es
Alessio Branchini
@nl
prefLabel
Alessio Branchini
@ast
Alessio Branchini
@en
Alessio Branchini
@es
Alessio Branchini
@nl
P106
P1153
25925774000
P31
P496
0000-0002-6113-2694